Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of Blood, Blood Forming Organs and Immunologic DisordersDRG 800-splenic-procedures-with-cc
    Ask Trek AI about this page

    Splenic Procedures with CC: Inpatient Reimbursement Overview

    DRG 800 encompasses inpatient admissions for splenic procedures when a Complication or Comorbidity is present, covering splenectomy and related operative care. This Diagnosis-Related Group matters because the Complication or Comorbidity status increases resource use and determines Medicare prospective payment classification.

    Customize your policy alerts

    Sign up for drg 800 policy alerts

    Get alerted when payer policies referencing 800 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 800 Overview

    DRG 800 covers inpatient admissions involving splenic procedures performed for therapeutic or diagnostic reasons when a Complication or Comorbidity is present. The clinical scope includes splenectomy, partial splenectomy, splenic repair, and related operative management in the setting of additional clinical complexity. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity elevates resource intensity and affects prospective payment classification under Centers for Medicare & Medicaid Services rules. Accurate coding and documentation of the splenic procedure and the Complication or Comorbidity drive payment assignment for these hospital stays.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute hemostatic intervention studies: randomized or prospective cohort trials comparing different operative and perioperative strategies to control hemorrhage from traumatic or nontraumatic splenic injury (for example, rapid splenectomy versus splenic salvage procedures such as partial splenectomy or repair). These studies target hemodynamically unstable patients or those with significant concomitant injuries, assessing outcomes like operative time, transfusion requirements, in-hospital mortality, and complication rates. Results inform surgeons, hospital administrators, and payers about resource use and short-term outcomes that drive inpatient costs and admission intensity for this DRG.
    • Comparative effectiveness studies of perioperative management and complication reduction: observational or pragmatic trials evaluating approaches such as infection prophylaxis protocols, thromboprophylaxis regimens, and standardized postoperative care pathways in patients undergoing splenic procedures with complicating conditions (the CC component may include sepsis, coagulopathy, or major comorbidity). These studies enroll a broader, often older or comorbid inpatient population to compare rates of surgical site infection, venous thromboembolism, length of stay, and readmission. Findings are relevant for clinicians and payers because optimizing perioperative protocols can reduce complications, shorten stays, and lower reimbursement-related expenditures for cases classified under this DRG.
    • Post-discharge outcomes and immunologic sequelae research: longitudinal cohort studies or registry analyses that follow patients after splenic removal or significant splenic injury to assess long-term risks such as overwhelming post-splenectomy infection, vaccine response, and quality of life, as well as utilization of outpatient preventive care (vaccination, antibiotic prophylaxis) and readmissions. These studies focus on survivors of index hospitalization—often patients with complex comorbidity profiles—and evaluate how inpatient education and discharge planning affect downstream infections and healthcare use. This research matters to providers and payers because preventing late infectious complications and avoidable readmissions influences total cost of care and value-based performance metrics tied to this DRG.

    Related Codes

    799-SPLENIC-PROCEDURES-WITH-MCC

    Splenic Procedures with MCC: Inpatient Reimbursement Overview

    801-SPLENIC-PROCEDURES-WITHOUT-CC-MCC

    Splenic Procedures without CC/MCC: Inpatient Reimbursement Overview

    802-OTHER-O-R-PROCEDURES-OF-THE-BLOOD-AND-BLOOD-FORMING-ORGANS-WITH-MCC

    Other O.R. Procedures of the Blood and Blood Forming Organs with MCC: Inpatient Reimbursement Overview

    803-OTHER-O-R-PROCEDURES-OF-THE-BLOOD-AND-BLOOD-FORMING-ORGANS-WITH-CC

    Other O.R. Procedures of the Blood and Blood Forming Organs with CC: Inpatient Reimbursement Overview

    804-OTHER-O-R-PROCEDURES-OF-THE-BLOOD-AND-BLOOD-FORMING-ORGANS-WITHOUT-CC-MCC

    Other O.R. Procedures of the Blood and Blood Forming Organs without CC/MCC: Inpatient Reimbursement Overview

    808-MAJOR-HEMATOLOGICAL-AND-IMMUNOLOGICAL-DIAGNOSES-EXCEPT-SICKLE-CELL-CRISIS-AND-COAGULATION-DISORDERS-WITH-MCC

    Major Hematological and Immunological Diagnoses: Inpatient Reimbursement Overview

    809-MAJOR-HEMATOLOGICAL-AND-IMMUNOLOGICAL-DIAGNOSES-EXCEPT-SICKLE-CELL-CRISIS-AND-COAGULATION-DISORDERS-WITH-CC

    Major Hematological and Immunological Diagnoses: Inpatient Reimbursement Overview

    810-MAJOR-HEMATOLOGICAL-AND-IMMUNOLOGICAL-DIAGNOSES-EXCEPT-SICKLE-CELL-CRISIS-AND-COAGULATION-DISORDERS-WITHOUT-CC-MCC

    Major Hematological and Immunological Diagnoses: Inpatient Reimbursement Overview

    811-RED-BLOOD-CELL-DISORDERS-WITH-MCC

    Red Blood Cell Disorders with MCC: Inpatient Reimbursement Overview

    812-RED-BLOOD-CELL-DISORDERS-WITHOUT-MCC

    Red Blood Cell Disorders without MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 14

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.